Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
International Journal of Clinical Pharmacology and Therapeutics
|
October 1, 1995
Adaptive control of drug dosage regimens using maximum a posteriori probability Bayesian fitting
J H Proost
Journal of Pharmaceutical Sciences
|
July 1, 1985
Wagner's exact Loo-Riegelman equation: the need for a criterion to choose between the linear and logarithmic trapezoidal rule
J H Proost
Clinical Pharmacology and Therapeutics
|
May 1, 1999
Do computational results depend on PC processors?
J H Proost
International Journal of Clinical Pharmacology and Therapeutics
|
August 30, 2007
Validation of limited sampling models (LSM) for estimating AUC in therapeutic drug monitoring--is a separate validation group required?
J H Proost
International Journal of Clinical Pharmacology and Therapeutics
|
June 28, 2006
Pharmacokinetic simulations and AUC: center specificity in the limited sampling model
J H Proost
Journal of Pharmaceutical Sciences
|
October 1, 1985
Application of a numerical deconvolution technique in the assessment of bioavailability
J H Proost
European Journal of Anaesthesiology. Supplement
|
January 5, 2002
A pharmacokinetic-dynamic explanation of the rapid onset-offset of rapacuronium
J H Proost, P M Wright
Computers in Biology and Medicine
|
May 1, 1992
MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring
J H Proost, D K Meijer
International Journal of Clinical Pharmacology and Therapeutics
|
January 6, 2004
Dose individualization in PharmDIS-e+
J H Proost, N C Punt
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|
March 17, 2000
Pharmacokinetic aspects of the onset of action of neuromuscular blocking agents
J H Proost, J M Wierda
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
International Journal of Clinical Pharmacology and Therapeutics
|
October 1, 1995
Adaptive control of drug dosage regimens using maximum a posteriori probability Bayesian fitting
J H Proost
Journal of Pharmaceutical Sciences
|
July 1, 1985
Wagner's exact Loo-Riegelman equation: the need for a criterion to choose between the linear and logarithmic trapezoidal rule
J H Proost
Clinical Pharmacology and Therapeutics
|
May 1, 1999
Do computational results depend on PC processors?
J H Proost
International Journal of Clinical Pharmacology and Therapeutics
|
August 30, 2007
Validation of limited sampling models (LSM) for estimating AUC in therapeutic drug monitoring--is a separate validation group required?
J H Proost
International Journal of Clinical Pharmacology and Therapeutics
|
June 28, 2006
Pharmacokinetic simulations and AUC: center specificity in the limited sampling model
J H Proost
Journal of Pharmaceutical Sciences
|
October 1, 1985
Application of a numerical deconvolution technique in the assessment of bioavailability
J H Proost
European Journal of Anaesthesiology. Supplement
|
January 5, 2002
A pharmacokinetic-dynamic explanation of the rapid onset-offset of rapacuronium
J H Proost, P M Wright
Computers in Biology and Medicine
|
May 1, 1992
MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring
J H Proost, D K Meijer
International Journal of Clinical Pharmacology and Therapeutics
|
January 6, 2004
Dose individualization in PharmDIS-e+
J H Proost, N C Punt
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|
March 17, 2000
Pharmacokinetic aspects of the onset of action of neuromuscular blocking agents
J H Proost, J M Wierda
Page
of 7